Item talk:Q332210
From geokb
{
"OpenAlex": {
"associated_institutions": [
{
"id": "https://openalex.org/I4210091819",
"ror": "https://ror.org/00czwhy51",
"display_name": "Immunocore (United States)",
"country_code": "US",
"type": "company",
"relationship": "child"
}
],
"cited_by_count": 7066,
"country_code": "GB",
"counts_by_year": [
{
"year": 2024,
"works_count": 25,
"cited_by_count": 809
},
{
"year": 2023,
"works_count": 29,
"cited_by_count": 1019
},
{
"year": 2022,
"works_count": 29,
"cited_by_count": 1020
},
{
"year": 2021,
"works_count": 32,
"cited_by_count": 779
},
{
"year": 2020,
"works_count": 25,
"cited_by_count": 621
},
{
"year": 2019,
"works_count": 19,
"cited_by_count": 500
},
{
"year": 2018,
"works_count": 12,
"cited_by_count": 445
},
{
"year": 2017,
"works_count": 13,
"cited_by_count": 394
},
{
"year": 2016,
"works_count": 10,
"cited_by_count": 353
},
{
"year": 2015,
"works_count": 9,
"cited_by_count": 355
},
{
"year": 2014,
"works_count": 8,
"cited_by_count": 230
},
{
"year": 2013,
"works_count": 10,
"cited_by_count": 238
},
{
"year": 2012,
"works_count": 9,
"cited_by_count": 154
}
],
"created_date": "2022-02-02",
"display_name": "Immunocore (United Kingdom)",
"display_name_acronyms": [],
"display_name_alternatives": [],
"geo": {
"city": "Abingdon",
"geonames_city_id": "2657780",
"region": null,
"country_code": "GB",
"country": "United Kingdom",
"latitude": 51.62288,
"longitude": -1.296983
},
"homepage_url": "http://www.immunocore.com/",
"ids": {
"openalex": "https://openalex.org/I4210104024",
"ror": "https://ror.org/014xzez86",
"grid": "grid.450850.c"
},
"image_thumbnail_url": null,
"image_url": null,
"international": {
"display_name": {
"en": "Immunocore (United Kingdom)"
}
},
"is_super_system": false,
"lineage": [
"https://openalex.org/I4210104024"
],
"repositories": [],
"roles": [
{
"role": "institution",
"id": "https://openalex.org/I4210104024",
"works_count": 251
}
],
"ror": "https://ror.org/014xzez86",
"summary_stats": {
"2yr_mean_citedness": 6.032786885245901,
"h_index": 40,
"i10_index": 87
},
"topic_share": [
{
"id": "https://openalex.org/T11328",
"display_name": "Ocular Cancer Research and Treatment",
"value": 0.0005917,
"subfield": {
"id": "https://openalex.org/subfields/2731",
"display_name": "Ophthalmology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11491",
"display_name": "Chimeric Antigen Receptor T Cell Therapy",
"value": 0.0005855,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10580",
"display_name": "Immunobiology of Dendritic Cells",
"value": 0.0003108,
"subfield": {
"id": "https://openalex.org/subfields/2403",
"display_name": "Immunology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T12576",
"display_name": "Prediction of Peptide-MHC Binding Affinity",
"value": 0.0001864,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10158",
"display_name": "Cancer Immunotherapy",
"value": 0.0001469,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10031",
"display_name": "Regulatory T Cell Development and Function",
"value": 0.0001264,
"subfield": {
"id": "https://openalex.org/subfields/2403",
"display_name": "Immunology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T11020",
"display_name": "Natural Killer Cells in Immunity",
"value": 0.000126,
"subfield": {
"id": "https://openalex.org/subfields/2403",
"display_name": "Immunology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T11016",
"display_name": "Therapeutic Antibodies: Development, Engineering, and Applications",
"value": 0.0001115,
"subfield": {
"id": "https://openalex.org/subfields/2741",
"display_name": "Radiology, Nuclear Medicine and Imaging"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10782",
"display_name": "Nanotechnology and Imaging for Cancer Therapy and Diagnosis",
"value": 0.0001049,
"subfield": {
"id": "https://openalex.org/subfields/2204",
"display_name": "Biomedical Engineering"
},
"field": {
"id": "https://openalex.org/fields/22",
"display_name": "Engineering"
},
"domain": {
"id": "https://openalex.org/domains/3",
"display_name": "Physical Sciences"
}
},
{
"id": "https://openalex.org/T12534",
"display_name": "Targeted Protein Degradation in Biomedical Research",
"value": 8.21e-05,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T12255",
"display_name": "Immunogenicity of Biosimilar Therapeutics in Drug Development",
"value": 8.15e-05,
"subfield": {
"id": "https://openalex.org/subfields/2403",
"display_name": "Immunology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T14364",
"display_name": "Role of Clusterin in Cancer and Disease",
"value": 8.01e-05,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11041",
"display_name": "Ubiquitin-Proteasome Proteolytic Pathway",
"value": 7.73e-05,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T12820",
"display_name": "Chromatin Remodeling in Cancer and Development",
"value": 6.53e-05,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10112",
"display_name": "Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome",
"value": 5.06e-05,
"subfield": {
"id": "https://openalex.org/subfields/2406",
"display_name": "Virology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T13223",
"display_name": "Role of CCN Proteins in Signaling Pathways",
"value": 4.45e-05,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T11962",
"display_name": "Molecular Mechanisms of Cardiac Remodeling and Repair",
"value": 4.3e-05,
"subfield": {
"id": "https://openalex.org/subfields/2705",
"display_name": "Cardiology and Cardiovascular Medicine"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T12789",
"display_name": "Molecular Mechanisms of Planarian Regeneration",
"value": 4.08e-05,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T13657",
"display_name": "Aortic Atherosclerotic Disease and Embolic Events",
"value": 4.01e-05,
"subfield": {
"id": "https://openalex.org/subfields/2740",
"display_name": "Pulmonary and Respiratory Medicine"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11501",
"display_name": "Transforming Growth Factor Beta Signaling Pathway",
"value": 3.61e-05,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T11190",
"display_name": "3D Bioprinting Technology",
"value": 3.56e-05,
"subfield": {
"id": "https://openalex.org/subfields/2204",
"display_name": "Biomedical Engineering"
},
"field": {
"id": "https://openalex.org/fields/22",
"display_name": "Engineering"
},
"domain": {
"id": "https://openalex.org/domains/3",
"display_name": "Physical Sciences"
}
},
{
"id": "https://openalex.org/T10649",
"display_name": "Diagnosis and Treatment of Multiple Myeloma",
"value": 3.25e-05,
"subfield": {
"id": "https://openalex.org/subfields/2720",
"display_name": "Hematology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11124",
"display_name": "Protein Aggregation and Biopharmaceutical Stability",
"value": 3.14e-05,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T11663",
"display_name": "Recombinant Protein Production in Mammalian and Insect Cells",
"value": 3.08e-05,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T11255",
"display_name": "Microfluidic Techniques for Particle Manipulation and Separation",
"value": 2.84e-05,
"subfield": {
"id": "https://openalex.org/subfields/2204",
"display_name": "Biomedical Engineering"
},
"field": {
"id": "https://openalex.org/fields/22",
"display_name": "Engineering"
},
"domain": {
"id": "https://openalex.org/domains/3",
"display_name": "Physical Sciences"
}
}
],
"topics": [
{
"id": "https://openalex.org/T10580",
"display_name": "Immunobiology of Dendritic Cells",
"count": 110,
"subfield": {
"id": "https://openalex.org/subfields/2403",
"display_name": "Immunology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T11491",
"display_name": "Chimeric Antigen Receptor T Cell Therapy",
"count": 99,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11020",
"display_name": "Natural Killer Cells in Immunity",
"count": 55,
"subfield": {
"id": "https://openalex.org/subfields/2403",
"display_name": "Immunology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T11016",
"display_name": "Therapeutic Antibodies: Development, Engineering, and Applications",
"count": 53,
"subfield": {
"id": "https://openalex.org/subfields/2741",
"display_name": "Radiology, Nuclear Medicine and Imaging"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11328",
"display_name": "Ocular Cancer Research and Treatment",
"count": 47,
"subfield": {
"id": "https://openalex.org/subfields/2731",
"display_name": "Ophthalmology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10031",
"display_name": "Regulatory T Cell Development and Function",
"count": 37,
"subfield": {
"id": "https://openalex.org/subfields/2403",
"display_name": "Immunology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10158",
"display_name": "Cancer Immunotherapy",
"count": 33,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10782",
"display_name": "Nanotechnology and Imaging for Cancer Therapy and Diagnosis",
"count": 15,
"subfield": {
"id": "https://openalex.org/subfields/2204",
"display_name": "Biomedical Engineering"
},
"field": {
"id": "https://openalex.org/fields/22",
"display_name": "Engineering"
},
"domain": {
"id": "https://openalex.org/domains/3",
"display_name": "Physical Sciences"
}
},
{
"id": "https://openalex.org/T12576",
"display_name": "Prediction of Peptide-MHC Binding Affinity",
"count": 13,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T11041",
"display_name": "Ubiquitin-Proteasome Proteolytic Pathway",
"count": 13,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10112",
"display_name": "Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome",
"count": 11,
"subfield": {
"id": "https://openalex.org/subfields/2406",
"display_name": "Virology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T12534",
"display_name": "Targeted Protein Degradation in Biomedical Research",
"count": 7,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T12255",
"display_name": "Immunogenicity of Biosimilar Therapeutics in Drug Development",
"count": 6,
"subfield": {
"id": "https://openalex.org/subfields/2403",
"display_name": "Immunology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T11190",
"display_name": "3D Bioprinting Technology",
"count": 6,
"subfield": {
"id": "https://openalex.org/subfields/2204",
"display_name": "Biomedical Engineering"
},
"field": {
"id": "https://openalex.org/fields/22",
"display_name": "Engineering"
},
"domain": {
"id": "https://openalex.org/domains/3",
"display_name": "Physical Sciences"
}
},
{
"id": "https://openalex.org/T11663",
"display_name": "Recombinant Protein Production in Mammalian and Insect Cells",
"count": 6,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10613",
"display_name": "Gene Therapy Techniques and Applications",
"count": 6,
"subfield": {
"id": "https://openalex.org/subfields/1311",
"display_name": "Genetics"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10417",
"display_name": "Advancements in Lung Cancer Research",
"count": 5,
"subfield": {
"id": "https://openalex.org/subfields/2740",
"display_name": "Pulmonary and Respiratory Medicine"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11482",
"display_name": "RNA Methylation and Modification in Gene Expression",
"count": 5,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10521",
"display_name": "Ribosome Structure and Translation Mechanisms",
"count": 5,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10649",
"display_name": "Diagnosis and Treatment of Multiple Myeloma",
"count": 4,
"subfield": {
"id": "https://openalex.org/subfields/2720",
"display_name": "Hematology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11124",
"display_name": "Protein Aggregation and Biopharmaceutical Stability",
"count": 4,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T11255",
"display_name": "Microfluidic Techniques for Particle Manipulation and Separation",
"count": 4,
"subfield": {
"id": "https://openalex.org/subfields/2204",
"display_name": "Biomedical Engineering"
},
"field": {
"id": "https://openalex.org/fields/22",
"display_name": "Engineering"
},
"domain": {
"id": "https://openalex.org/domains/3",
"display_name": "Physical Sciences"
}
},
{
"id": "https://openalex.org/T10981",
"display_name": "Epidemiology and Management of Cytomegalovirus Infection",
"count": 4,
"subfield": {
"id": "https://openalex.org/subfields/2713",
"display_name": "Epidemiology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T12505",
"display_name": "Role of Fibroblast Activation in Cancer Progression",
"count": 4,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10211",
"display_name": "Computational Methods in Drug Discovery",
"count": 4,
"subfield": {
"id": "https://openalex.org/subfields/1703",
"display_name": "Computational Theory and Mathematics"
},
"field": {
"id": "https://openalex.org/fields/17",
"display_name": "Computer Science"
},
"domain": {
"id": "https://openalex.org/domains/3",
"display_name": "Physical Sciences"
}
}
],
"type": "company",
"type_id": "https://openalex.org/institution-types/company",
"updated_date": "2024-09-07T16:04:48.863710",
"works_api_url": "https://api.openalex.org/works?filter=institutions.id:I4210104024",
"works_count": 251,
"x_concepts": [
{
"id": "https://openalex.org/C86803240",
"wikidata": "https://www.wikidata.org/wiki/Q420",
"display_name": "Biology",
"level": 0,
"score": 98.4
},
{
"id": "https://openalex.org/C71924100",
"wikidata": "https://www.wikidata.org/wiki/Q11190",
"display_name": "Medicine",
"level": 0,
"score": 95.2
},
{
"id": "https://openalex.org/C54355233",
"wikidata": "https://www.wikidata.org/wiki/Q7162",
"display_name": "Genetics",
"level": 1,
"score": 92.8
},
{
"id": "https://openalex.org/C203014093",
"wikidata": "https://www.wikidata.org/wiki/Q101929",
"display_name": "Immunology",
"level": 1,
"score": 74.5
},
{
"id": "https://openalex.org/C185592680",
"wikidata": "https://www.wikidata.org/wiki/Q2329",
"display_name": "Chemistry",
"level": 0,
"score": 74.1
},
{
"id": "https://openalex.org/C126322002",
"wikidata": "https://www.wikidata.org/wiki/Q11180",
"display_name": "Internal medicine",
"level": 1,
"score": 72.5
},
{
"id": "https://openalex.org/C55493867",
"wikidata": "https://www.wikidata.org/wiki/Q7094",
"display_name": "Biochemistry",
"level": 1,
"score": 68.1
},
{
"id": "https://openalex.org/C8891405",
"wikidata": "https://www.wikidata.org/wiki/Q1059",
"display_name": "Immune system",
"level": 2,
"score": 66.5
},
{
"id": "https://openalex.org/C2776090121",
"wikidata": "https://www.wikidata.org/wiki/Q193529",
"display_name": "T cell",
"level": 3,
"score": 49.8
},
{
"id": "https://openalex.org/C147483822",
"wikidata": "https://www.wikidata.org/wiki/Q103537",
"display_name": "Antigen",
"level": 2,
"score": 49.4
},
{
"id": "https://openalex.org/C502942594",
"wikidata": "https://www.wikidata.org/wiki/Q3421914",
"display_name": "Cancer research",
"level": 1,
"score": 49.4
},
{
"id": "https://openalex.org/C121608353",
"wikidata": "https://www.wikidata.org/wiki/Q12078",
"display_name": "Cancer",
"level": 2,
"score": 44.2
},
{
"id": "https://openalex.org/C19317047",
"wikidata": "https://www.wikidata.org/wiki/Q412037",
"display_name": "T-cell receptor",
"level": 4,
"score": 35.9
},
{
"id": "https://openalex.org/C202751555",
"wikidata": "https://www.wikidata.org/wiki/Q221681",
"display_name": "In vitro",
"level": 2,
"score": 33.5
},
{
"id": "https://openalex.org/C95444343",
"wikidata": "https://www.wikidata.org/wiki/Q7141",
"display_name": "Cell biology",
"level": 1,
"score": 32.7
},
{
"id": "https://openalex.org/C167672396",
"wikidata": "https://www.wikidata.org/wiki/Q417800",
"display_name": "CD8",
"level": 3,
"score": 31.9
},
{
"id": "https://openalex.org/C2777701055",
"wikidata": "https://www.wikidata.org/wiki/Q1427096",
"display_name": "Immunotherapy",
"level": 3,
"score": 31.1
},
{
"id": "https://openalex.org/C154317977",
"wikidata": "https://www.wikidata.org/wiki/Q376266",
"display_name": "Cytotoxic T cell",
"level": 3,
"score": 27.5
},
{
"id": "https://openalex.org/C159654299",
"wikidata": "https://www.wikidata.org/wiki/Q79460",
"display_name": "Antibody",
"level": 2,
"score": 25.1
},
{
"id": "https://openalex.org/C2777658100",
"wikidata": "https://www.wikidata.org/wiki/Q180614",
"display_name": "Melanoma",
"level": 2,
"score": 25.1
},
{
"id": "https://openalex.org/C104317684",
"wikidata": "https://www.wikidata.org/wiki/Q7187",
"display_name": "Gene",
"level": 2,
"score": 25.1
},
{
"id": "https://openalex.org/C142724271",
"wikidata": "https://www.wikidata.org/wiki/Q7208",
"display_name": "Pathology",
"level": 1,
"score": 23.9
},
{
"id": "https://openalex.org/C121332964",
"wikidata": "https://www.wikidata.org/wiki/Q413",
"display_name": "Physics",
"level": 0,
"score": 23.1
},
{
"id": "https://openalex.org/C170493617",
"wikidata": "https://www.wikidata.org/wiki/Q208467",
"display_name": "Receptor",
"level": 2,
"score": 21.1
},
{
"id": "https://openalex.org/C143998085",
"wikidata": "https://www.wikidata.org/wiki/Q162555",
"display_name": "Oncology",
"level": 1,
"score": 21.1
}
],
"id": "https://openalex.org/I4210104024"
}
}
